<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Jacobs, D.C.</title>
    <link>http://repub.eur.nl/res/aut/12664/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Vdelta2-Jalpha rearrangements are frequent in precursor-B-acute lymphoblastic leukemia but rare in normal lymphoid cells (Article)</title>
      <link>http://repub.eur.nl/res/pub/8187/</link>
      <pubDate>2004-01-01T00:00:00Z</pubDate>
      <description>The frequently occurring T-cell receptor delta (TCRD) deletions in
      precursor-B-acute lymphoblastic leukemia (precursor-B-ALL) are assumed to
      be mainly caused by Vdelta2-Jalpha rearrangements. We designed a multiplex
      polymerase chain reaction tified clonal Vdelta2-Jalpha rearrangements in
      141 of 339 (41%) childhood and 8 of 22 (36%) adult precursor-B-ALL. A
      significant proportion (44%) of Vdelta2-Jalpha rearrangements in childhood
      precursor-B-ALL were oligoclonal. Sequence analysis showed preferential
      usage of the Jalpha29 gene segment in 54% of rearrangements. The remaining
      Vdelta2-Jalpha rearrangements used 26 other Jalpha segments, which
      included 2 additional clusters, one involving the most upstream Jalpha
      segments (ie, Jalpha48 to Jalpha61; 23%) and the second cluster located
      around the Jalpha9 gene segment (7%). Real-time quantitative PCR studies
      of normal lymphoid cells showed that Vdelta2 rearrangements to upstream
      Jalpha segments occurred at low levels in the thymus (10(-2) to 10(-3))
      and were rare (generally below 10(-3)) in B-cell precursors and mature T
      cells. Vdelta2-Jalpha29 rearrangements were virtually absent in normal
      lymphoid cells. The monoclonal Vdelta2-Jalpha rearrangements in
      precursor-B-ALL may serve as patient-specific targets for detection of
      minimal residual disease, because they show high sensitivity (10(-4) or
      less in most cases) and good stability (88% of rearrangements preserved at
      relapse).</description>
    </item>
  </channel>
</rss>